David Buchsbaum

David Buchsbaum has extensive work experience in the finance industry. David is currently the Chief Financial Officer at ADvantage Therapeutics Inc. Since 2015, they have served as the Managing Director Investment Banking at Dawson James Securities, Inc. Prior to that, they worked at Boxwood Research as a Principal from 2007 to 2015. From 2006 to 2007, they were the Director of Research at Jewelcor Management/Holtzman Opportunity Fund. David also held positions at Stanford Group Company as a Senior Vice President- Retail Equity Analyst from 2003 to 2005, Wachovia Securities as a Senior Vice President from 1999 to 2002, Interstate/Johnson Lane as a Vice President- Equity Research from 1998 to 1999, Southeast Research Partners as a Partner, Equity Research from 1994 to 1998, and Claire's Accessories as the Director of Investor Relations/Claire's Stores, Inc. from 1988 to 1993. Throughout their career, they have gained expertise in investment banking, equity research, portfolio management, and shareholder relations.

David Buchsbaum obtained a Bachelor of Science degree in Finance and Marketing from the University of Richmond - Robins School of Business, graduating in 1986. Following this, they pursued a Juris Doctor (JD) degree in Law from the University of Miami School of Law, completing their studies in 1993. There is no information available about their educational experience at the University of Pennsylvania.

In addition to their formal education, David Buchsbaum holds certifications in Series 7, 63, and 79 from the Financial Industry Regulatory Authority (FINRA), although the specific dates of when they obtained these certifications are not provided.